<DOC>
	<DOCNO>NCT00123643</DOCNO>
	<brief_summary>The purpose study compare vascular effect two commonly use diabetes medication , rosiglitazone glyburide type 2 diabetic patient .</brief_summary>
	<brief_title>Vascular Effects Rosiglitazone Versus Glyburide Type 2 Diabetic Patients</brief_title>
	<detailed_description>Rosiglitazone glyburide two commonly use diabetic medication show effective control blood glucose level . Since work different way , may different effect health blood vessel . This study assess medication well improve health artery separate blood glucose lower effect . Artery health assess non-invasively ultrasound . Certain marker atherosclerosis find blood also measure .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Rosiglitazone</mesh_term>
	<mesh_term>Glyburide</mesh_term>
	<criteria>Age 2575 year Type 2 diabetes mellitus less equal 10 year Prescreening HbA1c &gt; 6.5 % Screening 110 mg/dl &lt; fast plasma glucose &lt; 240 mg/dl 2 week metformin 500 mg twice daily ( b.i.d . ) Thiazolidinedione sulfonylurea use previous 30 day ( may undergo washout period 30 day ) Known contraindication use thiazolidinedione sulfonylurea Female patient must postmenopausal , surgically sterile , use adequate contraception Uncontrolled hyperlipidemia accord American Heart Association ( AHA ) guideline Subcutaneous insulin use Elevated liver enzymes ( 2.5 time upper limit reference range ) Serum creatinine &gt; 160 mmol/l Anemia ( Hb &lt; 11 g/dl men &lt; 10 g/dl woman ) Body mass index ( BMI ) &lt; 22 &gt; 42 kg/m2 History ketoacidosis Angina/New York Health Academy class III/IV cardiac insufficiency Electrocardiographic evidence mark left ventricular hypertrophy Uncontrolled hypertension accord AHA guideline Hemoglobinopathy</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>thiazolidinedione</keyword>
	<keyword>sulfonylurea</keyword>
	<keyword>endothelial function</keyword>
</DOC>